目的探讨基于《国际功能、残疾及健康分类》(International Classification of Functioning,Disability and Health,ICF)理念下膀胱标准化管理方案在间歇性导尿患者出院准备度中的应用效果,为有效指导临床决策、促进患者主动参与和自我...目的探讨基于《国际功能、残疾及健康分类》(International Classification of Functioning,Disability and Health,ICF)理念下膀胱标准化管理方案在间歇性导尿患者出院准备度中的应用效果,为有效指导临床决策、促进患者主动参与和自我管理能力提升、优化出院指导质量提供思路和参考。方法选取2022年5月—2023年8月在江苏省常州市德安医院康复中心住院的因脊髓损伤所致间歇性导尿患者50例为研究对象,采用抽样便利数据表法分为观察组与对照组,各25例,最终收集到有效数据为对照组23例,观察组24例。对照组实施常规膀胱管理方案;观察组实施基于ICF理念的膀胱标准化管理方案。比较2组患者出院准备度、自我效能水平,并调查2组患者出院后1个月膀胱自我管理能力情况。结果出院时观察组出院准备度总分为92(87.50,96.00)分,对照组为80(78.00,84.00)分,差异有统计学意义(P<0.05)。出院时观察组自我效能评分为(86.58±5.49)分,对照组为(74.87±7.68)分,差异有统计学意义(P<0.05)。出院后1个月,观察组患者自我膀胱管理知识掌握与自我管理能力总分分别为(63.17±1.79)分、(83.21±4.06)分,均高于对照组的(42.52±3.23)分、(66.57±5.23)分,差异有统计学意义(P<0.05)。结论基于ICF理念的膀胱标准化管理方案可以提高间歇性导尿患者的自我效能和膀胱管理能力,以获得最佳的出院准备度,促进患者完成从医院专业照护到自我照护的顺利过渡,提升医疗服务效率和质量,改善出院后生活质量。展开更多
BACKGROUND Colorectal polyps are frequently observed in patients with type 2 diabetes mellitus(DM),posing a significant risk for colorectal cancer.Metformin,a widely prescribed biguanidine drug for type 2 DM,has been ...BACKGROUND Colorectal polyps are frequently observed in patients with type 2 diabetes mellitus(DM),posing a significant risk for colorectal cancer.Metformin,a widely prescribed biguanidine drug for type 2 DM,has been suggested to have potential chemoprophylactic effects against various cancers.AIM To explore the correlation between colorectal polyps and metformin use in type 2 DM patients.METHODS Type 2 DM patients were categorized into polyp and non-polyp groups.Following this,all patients were categorized into the type 2 DM-metformin,type 2 DM-non-metformin,and non-type 2 DM groups.Based on the baseline colonoscopy results,we performed pairwise comparisons of the incidence of colorectal polyps among the three groups.Additionally,we analyzed the relationship between colorectal polyps and the duration of metformin use and between the size and number of polyps and metformin use.Simultaneously,we focused on the specific pathological types of polyps and analyzed their relationship with metformin use.Finally,we compared the incidence of polyps between metformin and non-metformin groups according to the interval colonoscopy results.RESULTS The rate of metformin use in patients with colorectal polyps was 0.502 times that of patients without colorectal polyps[odds ratio(OR)=0.502,95%confidence interval(CI):0.365-0.689;P<0.001].The incidence of colorectal polyps did not differ significantly between the type 2 DM-metformin and non-type 2 DM groups(P>0.05).Furthermore,the correlations between the duration of metformin use and the incidence of colorectal polyps and between the size and number of polyps and metformin use were not statistically significant(P>0.05).Metformin use did not affect the incidence of colorectal polyps during interval colonoscopy(P>0.05).CONCLUSION Metformin use and colorectal polyp incidence in type 2 DM patients showed a negative correlation,independent of the hypoglycemic effect of metformin.展开更多
文摘目的探讨基于《国际功能、残疾及健康分类》(International Classification of Functioning,Disability and Health,ICF)理念下膀胱标准化管理方案在间歇性导尿患者出院准备度中的应用效果,为有效指导临床决策、促进患者主动参与和自我管理能力提升、优化出院指导质量提供思路和参考。方法选取2022年5月—2023年8月在江苏省常州市德安医院康复中心住院的因脊髓损伤所致间歇性导尿患者50例为研究对象,采用抽样便利数据表法分为观察组与对照组,各25例,最终收集到有效数据为对照组23例,观察组24例。对照组实施常规膀胱管理方案;观察组实施基于ICF理念的膀胱标准化管理方案。比较2组患者出院准备度、自我效能水平,并调查2组患者出院后1个月膀胱自我管理能力情况。结果出院时观察组出院准备度总分为92(87.50,96.00)分,对照组为80(78.00,84.00)分,差异有统计学意义(P<0.05)。出院时观察组自我效能评分为(86.58±5.49)分,对照组为(74.87±7.68)分,差异有统计学意义(P<0.05)。出院后1个月,观察组患者自我膀胱管理知识掌握与自我管理能力总分分别为(63.17±1.79)分、(83.21±4.06)分,均高于对照组的(42.52±3.23)分、(66.57±5.23)分,差异有统计学意义(P<0.05)。结论基于ICF理念的膀胱标准化管理方案可以提高间歇性导尿患者的自我效能和膀胱管理能力,以获得最佳的出院准备度,促进患者完成从医院专业照护到自我照护的顺利过渡,提升医疗服务效率和质量,改善出院后生活质量。
基金The International Institute of Population Health,Peking University Health Science Center,No.JKCJ202102The National Key Clinical Specialty Construction Projects,No.2199000764。
文摘BACKGROUND Colorectal polyps are frequently observed in patients with type 2 diabetes mellitus(DM),posing a significant risk for colorectal cancer.Metformin,a widely prescribed biguanidine drug for type 2 DM,has been suggested to have potential chemoprophylactic effects against various cancers.AIM To explore the correlation between colorectal polyps and metformin use in type 2 DM patients.METHODS Type 2 DM patients were categorized into polyp and non-polyp groups.Following this,all patients were categorized into the type 2 DM-metformin,type 2 DM-non-metformin,and non-type 2 DM groups.Based on the baseline colonoscopy results,we performed pairwise comparisons of the incidence of colorectal polyps among the three groups.Additionally,we analyzed the relationship between colorectal polyps and the duration of metformin use and between the size and number of polyps and metformin use.Simultaneously,we focused on the specific pathological types of polyps and analyzed their relationship with metformin use.Finally,we compared the incidence of polyps between metformin and non-metformin groups according to the interval colonoscopy results.RESULTS The rate of metformin use in patients with colorectal polyps was 0.502 times that of patients without colorectal polyps[odds ratio(OR)=0.502,95%confidence interval(CI):0.365-0.689;P<0.001].The incidence of colorectal polyps did not differ significantly between the type 2 DM-metformin and non-type 2 DM groups(P>0.05).Furthermore,the correlations between the duration of metformin use and the incidence of colorectal polyps and between the size and number of polyps and metformin use were not statistically significant(P>0.05).Metformin use did not affect the incidence of colorectal polyps during interval colonoscopy(P>0.05).CONCLUSION Metformin use and colorectal polyp incidence in type 2 DM patients showed a negative correlation,independent of the hypoglycemic effect of metformin.
